Annual Shareholders Equity
$22.60 M
+$10.82 M+91.76%
31 December 2023
Summary:
Capricor Therapeutics annual stockholders equity is currently $22.60 million, with the most recent change of +$10.82 million (+91.76%) on 31 December 2023. During the last 3 years, it has fallen by -$8.77 million (-27.95%). CAPR annual shareholders equity is now -27.95% below its all-time high of $31.37 million, reached on 31 December 2021.CAPR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$68.27 M
+$56.76 M+493.49%
30 September 2024
Summary:
Capricor Therapeutics quarterly stockholders equity is currently $68.27 million, with the most recent change of +$56.76 million (+493.49%) on 30 September 2024. Over the past year, it has increased by +$45.66 million (+202.04%). CAPR quarterly shareholders equity is now at all-time high.CAPR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CAPR Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +202.0% |
| 3 y3 years | -27.9% | +117.6% |
| 5 y5 years | +230.5% | +898.1% |
CAPR Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -27.9% | +91.8% | at high | +3918.6% |
| 5 y | 5 years | -27.9% | +230.5% | at high | +3918.6% |
| alltime | all time | -27.9% | +461.7% | at high | +1049.2% |
Capricor Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $68.27 M(+493.5%) |
| June 2024 | - | $11.50 M(-37.6%) |
| Mar 2024 | - | $18.43 M(-18.4%) |
| Dec 2023 | $22.60 M(+91.8%) | $22.60 M(-1364.3%) |
| Sept 2023 | - | -$1.79 M(-165.5%) |
| June 2023 | - | $2.73 M(-56.0%) |
| Mar 2023 | - | $6.21 M(-47.3%) |
| Dec 2022 | $11.79 M(-62.4%) | $11.79 M(-23.6%) |
| Sept 2022 | - | $15.43 M(-17.6%) |
| June 2022 | - | $18.73 M(-24.0%) |
| Mar 2022 | - | $24.64 M(-21.4%) |
| Dec 2021 | $31.37 M(+11.2%) | $31.37 M(-14.6%) |
| Sept 2021 | - | $36.74 M(+10.1%) |
| June 2021 | - | $33.38 M(-8.2%) |
| Mar 2021 | - | $36.38 M(+29.0%) |
| Dec 2020 | $28.20 M(+312.3%) | $28.20 M(-7.3%) |
| Sept 2020 | - | $30.41 M(-3.9%) |
| June 2020 | - | $31.65 M(+230.0%) |
| Mar 2020 | - | $9.59 M(+40.3%) |
| Dec 2019 | $6.84 M(+48.2%) | $6.84 M(+91.6%) |
| Sept 2019 | - | $3.57 M(+51.0%) |
| June 2019 | - | $2.36 M(-36.8%) |
| Mar 2019 | - | $3.74 M(-19.0%) |
| Dec 2018 | $4.62 M(-58.9%) | $4.62 M(-33.9%) |
| Sept 2018 | - | $6.98 M(-27.5%) |
| June 2018 | - | $9.63 M(-8.6%) |
| Mar 2018 | - | $10.53 M(-6.2%) |
| Dec 2017 | $11.23 M(-380.4%) | $11.23 M(-362.9%) |
| Sept 2017 | - | -$4.27 M(-35.2%) |
| June 2017 | - | -$6.59 M(-8.4%) |
| Mar 2017 | - | -$7.19 M(+79.7%) |
| Dec 2016 | -$4.00 M(+288.0%) | -$4.00 M(-8253.2%) |
| Sept 2016 | - | $49.10 K(-101.0%) |
| June 2016 | - | -$5.12 M(+372.5%) |
| Mar 2016 | - | -$1.08 M(+5.0%) |
| Dec 2015 | -$1.03 M(-83.5%) | -$1.03 M(-153.6%) |
| Sept 2015 | - | $1.93 M(-57.7%) |
| June 2015 | - | $4.56 M(-37.8%) |
| Mar 2015 | - | $7.32 M(-217.2%) |
| Dec 2014 | -$6.25 M(+1068.2%) | -$6.25 M(+39.7%) |
| Sept 2014 | - | -$4.47 M(+45.0%) |
| June 2014 | - | -$3.08 M(+85.9%) |
| Mar 2014 | - | -$1.66 M(+210.2%) |
| Dec 2013 | -$534.90 K(-110.9%) | -$534.90 K(-65.9%) |
| Sept 2013 | - | -$1.57 M(+27.1%) |
| June 2013 | - | -$1.23 M(+91.8%) |
| Mar 2013 | - | -$642.70 K(-113.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $4.89 M(+489.2%) | $4.89 M(>+9900.0%) |
| Sept 2012 | - | $27.20 K(-95.0%) |
| June 2012 | - | $542.30 K(+135.1%) |
| Mar 2012 | - | $230.70 K(-72.2%) |
| Dec 2011 | $830.70 K(-68.0%) | $830.70 K(-65.0%) |
| Sept 2011 | - | $2.37 M(-27.4%) |
| June 2011 | - | $3.27 M(+95.2%) |
| Mar 2011 | - | $1.67 M(-35.5%) |
| Dec 2010 | $2.60 M(-12.9%) | $2.60 M(-21.4%) |
| Sept 2010 | - | $3.30 M(-30.0%) |
| June 2010 | - | $4.72 M(+218.5%) |
| Mar 2010 | - | $1.48 M(-50.3%) |
| Dec 2009 | $2.98 M(-41.6%) | $2.98 M(-25.2%) |
| Sept 2009 | - | $3.98 M(+119.7%) |
| June 2009 | - | $1.81 M(-48.0%) |
| Mar 2009 | - | $3.48 M(-31.7%) |
| Dec 2008 | $5.10 M(-66.4%) | $5.10 M(-31.9%) |
| Sept 2008 | - | $7.49 M(-26.5%) |
| June 2008 | - | $10.19 M(-22.3%) |
| Mar 2008 | - | $13.11 M(-13.8%) |
| Dec 2007 | $15.20 M(<-9900.0%) | $15.20 M(-12.0%) |
| Sept 2007 | - | $17.27 M(<-9900.0%) |
| June 2007 | - | -$168.10 K(+15.9%) |
| Mar 2007 | - | -$145.10 K(+7.6%) |
| Dec 2006 | -$134.80 K(+73.7%) | -$134.80 K(+8.1%) |
| Sept 2006 | - | -$124.70 K(+39.0%) |
| June 2006 | - | -$89.70 K(+8.3%) |
| Mar 2006 | - | -$82.80 K(+6.7%) |
| Dec 2005 | -$77.60 K(+32.0%) | -$77.60 K(+10.1%) |
| Sept 2005 | - | -$70.50 K(+5.1%) |
| June 2005 | - | -$67.10 K(+4.5%) |
| Mar 2005 | - | -$64.20 K(+9.2%) |
| Dec 2004 | -$58.80 K(+44.5%) | -$58.80 K(+18.8%) |
| Sept 2004 | - | -$49.50 K(+7.6%) |
| June 2004 | - | -$46.00 K(+6.5%) |
| Mar 2004 | - | -$43.20 K(+6.1%) |
| Dec 2003 | -$40.70 K(+66.1%) | -$40.70 K(+15.3%) |
| Sept 2003 | - | -$35.30 K(+0.3%) |
| June 2003 | - | -$35.20 K(+24.8%) |
| Mar 2003 | - | -$28.20 K(+15.1%) |
| Dec 2002 | -$24.50 K(+175.3%) | -$24.50 K(+17.8%) |
| Sept 2002 | - | -$20.80 K(+70.5%) |
| June 2002 | - | -$12.20 K(+351.9%) |
| Mar 2002 | - | -$2700.00(-69.7%) |
| Dec 2001 | -$8900.00(-166.4%) | -$8900.00 |
| Dec 2000 | $13.40 K(-2333.3%) | - |
| Dec 1999 | -$600.00 | - |
FAQ
- What is Capricor Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Capricor Therapeutics?
- What is Capricor Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Capricor Therapeutics?
- What is Capricor Therapeutics quarterly shareholders equity year-on-year change?
What is Capricor Therapeutics annual stockholders equity?
The current annual shareholders equity of CAPR is $22.60 M
What is the all time high annual shareholders equity for Capricor Therapeutics?
Capricor Therapeutics all-time high annual stockholders equity is $31.37 M
What is Capricor Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of CAPR is $68.27 M
What is the all time high quarterly shareholders equity for Capricor Therapeutics?
Capricor Therapeutics all-time high quarterly stockholders equity is $68.27 M
What is Capricor Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, CAPR quarterly stockholders equity has changed by +$45.66 M (+202.04%)